Navigation Links
Insmed Announces Additional Information in Compliance With NASDAQ Rules
Date:3/18/2008

RICHMOND, Va., March 18 /PRNewswire-FirstCall/ -- Pursuant to NASDAQ Marketplace Rule 4350(b)(1)(B) (the "NASDAQ Rule") any Company whose securities are listed on one of the NASDAQ stock exchanges that receives a going concern audit opinion in one of its filings with the Securities and Exchange Commission is required to disseminate this information to the public. In compliance with this NASDAQ Rule, Insmed Incorporated (Nasdaq: INSM), today announced that it has received a going concern audit opinion for its financial statements dated as of December 31, 2007, and filed as part of its Annual Report on Form 10-K with the Securities and Exchange Commission. This going concern audit opinion was given because the Company's ability to continue as a going concern is dependent upon its ability to raise capital through securities offerings, debt financing and partnership agreements to fund on-going operations.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
2. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
3. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
4. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
5. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
6. Insmed to Appeal Delisting Notification From Nasdaq
7. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
8. Insmed Appoints Dennis M. Lanfear to Board Of Directors
9. Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Marteks lifesDHA
10. Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for VSII - Visionsense Stereoscopic Vision System
11. OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNAs, Including Its Phase III Compound Bevasiranib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...A and LACHEN, Switzerland, Dec. 4 ...unced that Dennis D. Curtin has been,selected to ...States. Curtin,had been Octapharma,s U.S. legal c... of Life Therapeutics, Inc. , The largest p...harma,recently acquired Life Therapeutics, the At...
(Date:12/4/2008)...SVILLE, Pa., Dec. 4 Raym...er of Met-Pro Corporation (NYSE: MPR ), announced...heir meeting on December 3, 2008, declared a quart...12, 2009 to shareholders of record at the close of...resents a 9.1% increase over the same period last ...
(Date:12/4/2008)...Company Introduces New Trade Name Onrigin(TM) for ...RNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC...nnouncements related to events in connection with ...ting at the Moscone Center in San Francisco from D...entation , , The Company announced that i...
(Date:12/4/2008)... CITY, Dec. 4 /PRNewswire-FirstCall/ - AEterna Zen...iopharmaceutical company focused on endocrine ther...nt and CEO, Juergen Engel, Ph.D., will take part i...ay With Newer And Better Agents" at the upcoming R...ednesday, December 10, 2008 at 4:30 pm (eastern ti...
Breaking Biology Technology:Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2Met-Pro Corporation Declares Quarterly Dividend 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
...o. and Wisconsin Gas LLC, collectively known as We...r relationship management software to automate, tr...nergies serves more than 1.1 million electric cust...and more than one million natural gas customers in...the utility,s Supply Chain team developed a seven-...
...a supplier of automatic identification and data co... have introduced version 4.0 of their NiceLabel so...e support for reading and programming radio freque...oved user interface. The system,s modules are also...t Access, Windows Event Log and Microsoft Excel. ,...
...Oconomowoc-based IT services provider, announced T...Cisco Systems . Starting July 1, the campaign will...mmunications markets. , ,PDS recently received Spe...sco in the three main areas in which the companies...s Express, and Wireless. In addition, PDS is certi...
... on behalf of Wisconsin consumers against Microsof... a result of last week,s state Supreme Court ruli...lstad, seeks a settlement fund for all Wisconsin c...ices. The suit,s major contention is that Wisconsi...t products, especially the Windows operating syste...
Other Biology Technology:Wisconsin Supreme Court rules against Microsoft 2
(Date:12/3/2008)...o. "FORE"...Though they may not help improve a pe...the way golfers think about the local country club... Missouri study. , "There are more than 17,000 g...y 70 percent of that land is not used for playing,...gy in the MU College of Arts and Science. "These m...
(Date:12/3/2008)...l-known fact in drug trials that individuals can r...o the active drug. On the other hand, it is diffi... from placebos. A team of researchers from Uppsal...und gene variants that can impact the placebo effe... those who respond to placebos. , The study, pub...
(Date:12/3/2008)...IL, December 3, 2008 Today, the International Soc...eading professional organization of stem cell rese...le development of safe and effective stem cell the...marizes the Guidelines for the Clinical Translatio... the December issue of Cell Stem Cell , the offic...
(Date:12/3/2008)... Synthetic biology promises to enable cheap, lifes...e who suffer from malaria, and to create innovativ...problems. But the science and its applications ar...ying God? Are these scientists purposely changing...ology researchers unintentionally equipping terror...
Breaking Biology News(10 mins):Golf course: Playing fields, wildlife sanctuaries or both 2Genes determine whether sugar pills work 2The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Synthetic biology: Is ethics a showstopper? 2Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 1Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 2Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues 815 3Three New Director Level Appointments at Adaptis 3770 1Three New Director Level Appointments at Adaptis 3770 2Three New Director Level Appointments at Adaptis 3770 3Pediatricians Awarded for Innovative Approaches to Combat Childhood Obesity 3766 1Pediatricians Awarded for Innovative Approaches to Combat Childhood Obesity 3766 2Pediatricians Awarded for Innovative Approaches to Combat Childhood Obesity 3766 3Pediatricians Awarded for Innovative Approaches to Combat Childhood Obesity 3766 4Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25 2007 1282 1Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25 2007 1282 2
...linking artificial sweeteners such as saccharin wi... on a sweet taste has guided researchers to an inc...ste. , Reporting in an advance online publicatio...enses Center describe how certain artificial sweet..., paradoxically inhibit sweet taste at high concen...
... Sydney,s Garvan Institute, in collaboration with ...for how cancer cells can escape normal growth cont... the new generation of cancer therapies. , They ha...n colon cancer. Lead researcher Associate Professo... large regions ?referred to as suburbs ?contain ge...
...lerates, quantifying the role of forests in the ca... simple predictors of forest biomass and carbon fl...ecology generated testable explanations, derived f...e range of ecological patterns. However, in two Ec...olleagues show that tree growth, mortality and abu...
...ed for genetics-versus-environment studies has joi...her species whose entire genomes have been sequenc...meeting in Bloomington this week, Indiana Universi... they,ve completed a "shotgun" sequence for Daphni...o high school biology students. , "Daphnia is imp...
Other Biology News:Sweet 'water taste' paradoxically predicts sweet taste inhibitors 2Cancer cells suppress large regions of DNA by a reversible process that can be tackled 2Diverse tropical forests defy metabolic ecology models 2Diverse tropical forests defy metabolic ecology models 3Diverse tropical forests defy metabolic ecology models 4Genome sequencing is for ecologists, too 2
Goat Anti-Horse IgG(T) Antibody, Unconjugated
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding
Mouse polyclonal antibody to MCFD2 - multiple coagulation factor deficiency 2
Rabbit polyclonal to ErbB 2 (phospho Y1248) ( Abpromise for all tested applications). entrezGeneID: 2064 SwissProtID: P04626
Biology Products: